Evaluation of effectiveness of pain control in patients after total hip replacement using the anaesthetic continuous-infusion device with bupivacaine

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN06050107

Enrollment

100

Registered

2007-04-13

Start date

2007-08-01

Completion date

Unknown

Last updated

2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritic hip Musculoskeletal Diseases Arthropathies

Interventions

Group I (25 patients): ACID intra-articular (above lessor trochanter) and normal saline 100 ml Group II (25 patients): ACID inter-muscular (between tensor facia lata and gluteal medius

Eligibility

Inclusion criteria

Inclusion criteria: Consecutive 100 patients with indications for total hip replacement.

Exclusion criteria

Exclusion criteria: Patients who refuse to join the clinical trial.

Design outcomes

Primary

Measure	Time frame
Pain control	—

Secondary

Measure	Time frame
Improve post-operative hip function and rehabilitation programs	—

Countries

Taiwan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026